Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical Inc (LFCR)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (LFCR) is currently associated with the following stock: Lifecore Biomedical Inc. (LFCR)
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.97 | 282,486 | $2,251,413.42 | 2,438,180 | 2022-11-25 | Filing | |
| $7.97 | 345,260 | $2,751,722.20 | 1,972,853 | 2022-11-25 | Filing |
News See All
What Contributes to Lifecore Biomedical's (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter.
Here’s the Analysis of LifeCore’s (LFCR) Growth Potential
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3
Laughing Water Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here.
Laughing Water Capital’s View on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?
Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for joining Lifecore's Fiscal 2025 Third Quarter Earnings Call. During the call, all participants will be in a listen-only mode.
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Micro Cap Stocks to Buy Now
Just as we overlook loose change, micro-cap stocks are often ignored for larger, more dominant enterprises.
Hedge Fund Resource Center